
AI is about to change healthcare. These 7 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Keyera, you need to be comfortable with a fee-based midstream business that is heavily tied to Western Canadian gas and NGL volumes, and to execution on its enlarged asset base. The strong Q2 rebound in earnings and the higher dividend support the short term catalyst of volume and cash flow recovery, but the biggest risk remains basin and integration pressures that could weigh on utilization and margins if momentum slips.
The 4.17% increase in the quarterly dividend to C$0.5625 per share is the most relevant announcement here, because it directly connects Q2’s improved results to shareholder payouts and tests how resilient Keyera’s cash generation is after a weaker first half. For investors focused on catalysts, that higher dividend intersects with ongoing integration and basin concentration risks, making it important to watch whether future quarters can sustain this higher payout level.
Yet behind the higher dividend and strong Q2, investors should be aware of how concentrated Keyera remains in the Western Canadian Sedimentary Basin and...
Read the full narrative on Keyera (it's free!)
Keyera's narrative projects CA$11.2 billion revenue and CA$990.4 million earnings by 2029. This requires 15.9% yearly revenue growth and about a CA$629 million earnings increase from CA$361.4 million today.
Uncover how Keyera's forecasts yield a CA$64.36 fair value, a 9% upside to its current price.
Four fair value estimates from the Simply Wall St Community span roughly C$50.77 to C$140.59 per share, underscoring how differently individual investors view Keyera’s prospects. When you set those views against the company’s growing dependence on higher contracted NGL and gas volumes to support recent dividend increases, it becomes clear that understanding both the upside and basin specific risks is critical before forming your own conviction.
Explore 4 other fair value estimates on Keyera - why the stock might be worth 14% less than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com